Volume 29, Issue 173 (6-2019)                   J Mazandaran Univ Med Sci 2019, 29(173): 164-175 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saeedi M, Farmoudeh A, Rezaeiroshan A. A Review on Current Status and Future Potential of Transdermal Patches as a Promising Drug Delivery System. J Mazandaran Univ Med Sci. 2019; 29 (173) :164-175
URL: http://jmums.mazums.ac.ir/article-1-12267-en.html
Abstract:   (650 Views)
Transdermal patches are now widely used in topical and transdermal drug delivery systems (TDDS). Up to now, TDDS has been used in several conditions, such as smoking cessation, analgesic effect, nausea, contraception, and hormone therapy. Basically, there are two types of transdermal patches: the reservoir-type patches and the matrix-type patches. First generation TDDS were designed for delivery of drugs in low-dose. In second-generation delivery systems, drug penetration was increased using chemical enhancers and iontophoresis. Several methods such as microneedles, electroporation, and cavitational ultrasound are used as the third generation of TDDS for targeting their effects to skin’s barrier layer of stratum corneum. Microneedles are currently studied through clinical trials as suitable delivery system for macromolecules and vaccines, such as insulin and influenza vaccine. This review article describes the structure of different types of transdermal patches and some marketed products. It also introduces a framework for present and future developments of percutaneous drug delivery by transdermal patches.
 
Full-Text [PDF 321 kb]   (389 Downloads)    
Type of Study: Review | Subject: Pharmaceutics

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb